Clobetasol Propionate Ophthalmic Suspension 0.05% (APP 13007) for the Treatment of Postsurgical Inflammation and Pain (Study CPN-302)

clobetasol nanosuspension (APP13007) - Formosa Labs, AimMax Therap

https://aao.apprisor.org/apsSession.cfm?id=PO183

Jeffrey H Levenson MD; Jason Bacharach, MD; Parag A Majmudar, MD; Ehsan Sadri MD FACS

Sep 24, 2024